Angela Melpignano
- Hematology top 5%
- Multiple Myeloma Research and Treatments 7
- Blood groups and transfusion 6
- Iron Metabolism and Disorders 5
- Acute Myeloid Leukemia Research 3
- Genetics top 5%
- Hemoglobinopathies and Related Disorders 8
- Chronic Lymphocytic Leukemia Research 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
-
- Erythrocyte Function and Pathophysiology 3
- Co-authors
- Antonio PigaGiovanni QuartaFilomena LongoGian Luca ForniRaffaella OrigaMatthew L. ShermanKenneth M. AttieErsi Voskaridou
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (4 papers)Clinical Therapeutics (1 paper)
- Partner nations
- ItalyGreeceUnited States
In The Last Decade
Angela Melpignano
20 papers receiving 352 citations
Peers
Comparison fields: 5 of 50
- Hematology 289
- Genetics 253
- Pediatrics, Perinatology and Child Health 57
- Obstetrics and Gynecology 13
- Physiology 42
Countries citing papers authored by Angela Melpignano
This map shows the geographic impact of Angela Melpignano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Melpignano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Melpignano more than expected).
Fields of papers citing papers by Angela Melpignano
This network shows the impact of papers produced by Angela Melpignano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Melpignano. The network helps show where Angela Melpignano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Angela Melpignano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 82 | |
| 2 | 2018 | 6 | |
| 3 | 2016 | 13 | |
| 4 | 2015 | 6 | |
| 5 | 2015 | 4 | |
| 6 | 2015 | 7 | |
| 7 | Azacitidine in the front-line treatment of therapy-related myeloid neoplasms: a multicenter case series. | 2015 | 6 |
| 8 | 2015 | 8 | |
| 9 | 2015 | 0 | |
| 10 | 2015 | 36 | |
| 11 | 2015 | 0 | |
| 12 | 2014 | 11 | |
| 13 | 2014 | 23 | |
| 14 | 2014 | 10 | |
| 15 | 2013 | 4 | |
| 16 | 2013 | 0 | |
| 17 | 2011 | 4 | |
| 18 | 2011 | 14 | |
| 19 | 2010 | 33 | |
| 20 | 1985 | 8 |
About Angela Melpignano
Angela Melpignano is a scholar working on Hematology, Genetics and Oncology, having authored 24 papers that have together received 358 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (8 papers), Multiple Myeloma Research and Treatments (7 papers), Blood groups and transfusion (6 papers), Iron Metabolism and Disorders (5 papers), Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Erythrocyte Function and Pathophysiology (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (289 citations), Genetics (253 citations) and Pediatrics, Perinatology and Child Health (57 citations). Angela Melpignano has collaborated with scholars based in Italy, Greece and United States. Frequent co-authors include Antonio Piga, Giovanni Quarta, Filomena Longo, Gian Luca Forni, Raffaella Origa, Matthew L. Sherman, Kenneth M. Attie, Ersi Voskaridou, Vincenzo Caruso and Silverio Perrotta. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.